Primary Sjogren's syndrome
Showing 1 - 25 of >10,000
Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)
Not yet recruiting
- Primary Sjögren's Syndrome
- Efgartigimod
- Placebo
- (no location specified)
Apr 5, 2023
Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)
Completed
- Primary Sjögren Syndrome
-
Rochester, New YorkUniversity of Rochester
Jul 6, 2022
Sjogren's Syndrome Trial (Anifrolumab)
Recruiting
- Sjogren's Syndrome
- Anifrolumab
- Placebo
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Dec 16, 2022
Sjögren and Gynecologic Considerations
Completed
- Primary Sjögren Syndrome
- +3 more
- Visual analogue scale (VAS) for dyspareunia
- +3 more
-
Ankara, TurkeyAnkara City Hospital
Jan 3, 2023
Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
Recruiting
- Dry Eye
- Cyclosporine
-
Beijing, ChinaPeking University Third Hospital
Oct 30, 2022
Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)
Recruiting
- Sjogren's Syndrome
- tofacitinib
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 24, 2022
Primary Sjögren Syndrome Patients
Active, not recruiting
- Sjogren's Syndrome
- Parallel Assignment
-
São Paulo, Sao Paulo, Brazil
- +1 more
Nov 7, 2022
Healthy Participants, Primary Sjögren's Syndrome Trial in Berlin (BMS-986325, Placebo for BMS-986325)
Recruiting
- Healthy Participants
- Primary Sjögren's Syndrome
- BMS-986325
- Placebo for BMS-986325
-
Berlin, GermanyLocal Institution - 0001
Jul 11, 2022
Primary Sjögren's Syndrome Painful Sensory Neuropathies Trial in Strasbourg (Privigen® 100mg/ml at the dose of 2g/kg of body
Recruiting
- Primary Sjögren's Syndrome Painful Sensory Neuropathies
- Privigen® 100mg/ml at the dose of 2g/kg of body weight
- NaCl 0,9%
-
Strasbourg, FranceUniversity Hospital, Strasbourg, france
Jul 7, 2022
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Completed
- Small Fiber Neuropathy
- Primary Sjögren Syndrome
- cutaneous silent period (CSP) measurement
-
Istanbul, Pendik, TurkeyMarmara University Pendik Education and Research Hospital
May 16, 2022
Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)
Recruiting
- Primary Sjögren's Syndrome
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022
Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))
Withdrawn
- Primary Sjogren's Syndrome
- tibulizumab (LY3090106)
-
Palo Alto, CaliforniaStanford University
Jan 12, 2022
Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)
Recruiting
- Primary Sjögren's Syndrome
- Iguratimod Tablets
- Hydroxychloroquine Sulfate Tablets
-
Hangzhou, Zhejiang, ChinaSecond affiliated hospital of zhejiang university,school of medi
Mar 23, 2022
Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)
Recruiting
- Sjogren's Syndrome
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 17, 2022
Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome
Recruiting
- Polymyalgia Rheumatica
- Sjogren's Syndrome
-
Brest, FranceCHRU Brest
Mar 28, 2022
Primary Sjögren's Syndrome (pSS) Trial in Le Kremlin-Bicêtre (Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate
Recruiting
- Primary Sjögren's Syndrome (pSS)
- Hydroxychloroquine 400mg/d
- +5 more
-
Le Kremlin-Bicêtre, FranceRaphaele Seror
May 2, 2022
Sjögren Syndrome, Sicca Syndrome Trial in São Paulo (N-acetylcysteine syrup, Placebo syrup)
Active, not recruiting
- Sjögren Syndrome
- Sicca Syndrome
- N-acetylcysteine syrup
- Placebo syrup
-
São Paulo, Sao Paulo, Brazil
- +1 more
Jun 13, 2022
Primary Sjögren's Syndrome (pSS) Trial in Seoul (SA001 Low dose, SA001 Mid dose, SA001 High dose)
Completed
- Primary Sjögren's Syndrome (pSS)
- SA001 Low dose
- +3 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 30, 2022
Sjogren's Syndrome (SS) Trial in Utrecht (Ravaglimab, Ravagalimab, Placebo)
Withdrawn
- Sjogren's Syndrome (SS)
- Ravaglimab
- +2 more
-
Utrecht, NetherlandsUniversitair Medisch Centrum Utrecht /ID# 214029
Jan 20, 2022
Primary Sjögren's Syndrome Trial in Yantai (Placebo, RC18 240 mg, RC18 160 mg)
Completed
- Primary Sjögren's Syndrome
- Placebo
- +2 more
-
Yantai, Shandong, ChinaRemegen,Ltd.
Jan 7, 2022
Sjogren's Syndrome, Interstitial Lung Disease, Organizing Pneumonia Trial in Stanford
Suspended
- Sjogren's Syndrome
- +7 more
-
Stanford, CaliforniaStanford University
Oct 25, 2022
Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety
Completed
- Sjogren's Syndrome
- +5 more
- FACT-F questionnaire
- +6 more
-
Yıldırım, Bursa, TurkeyKoray Ayar
Nov 29, 2021
Hand Functions in Newly Diagnosed Primary Sjögren's Syndrome
Recruiting
- Sjogren's Syndrome
- digital dynamometer
-
Konya, TurkeySelcuk University
Nov 4, 2021